Medidata Solutions Inc (MDSO)

HEALTH CARE: HEALTH CARE SERVICES
SIC: SERVICES-PREPACKAGED SOFTWARE

350 HUDSON ST., 9TH FLOOR NEW YORK, NY 10014

Medidata Solutions, Inc. provides hosted clinical development solutions for life science organizations worldwide. Its solutions include software and services that allow customers to achieve clinical results by streamlining the design, planning, and management of key aspects of the clinical development process, including protocol development, contract research organizations (CRO) negotiation, investigator contracting, the capture and management of clinical trial data, and the analysis and reporting of that data on a worldwide basis. The company primarily offers Medidata Rave, a comprehensive platform that integrates electronic data capture with a clinical data management system in a single solution. It also provides Medidata Designer application, a clinical trial protocol authoring tool that enables customers to write trial protocols and automatically configure Medidata Rave. In addition, Medidata Solutions offers Medidata Grants Manager, which enables its customers to benchmark their investigator budgets against industry data, as well as their own grant history; and Medidata CRO Contractor that focuses on benchmarks for CRO outsourcing, budgeting, and negotiation. Further, the company provides professional services, including implementation services to meet customers' data requirements for various indications; workflow design to meet the needs of different study phases and global regulatory requirements; and guidance on best practices for using its application services. Its customers include pharmaceutical, biotechnology, and medical device companies; academic institutions; clinical research organizations; and other entities engaged in clinical trials. The company markets and sells its application services through a direct sales force and through relationships with CROs and other strategic partners.

Data based on most recent fiscal year report
Market Cap3.666 Billion Shares Outstanding58.46 Million Avg Volume855.311 Thousand
1-Yr BETA vs S&P TR1.057 Current Ratio1.49 Quick Ratio1.49
View SEC Filings from MDSO instead.
Q2 2019 All Institutions Hedge Funds 1
To trade MDSO now:
Filers who had this stock in their top 10: 5 1 (0.1%)
13F Filers holding this stock: 290 49 (5.06%)
Aggregate 13F shares on 06/30/2019: 56.986 Million 9.088 Million
Aggregate 13F shares on 03/31/2019: 66.255 Million 6.423 Million
Percent change: -13.99% 41.50%
Funds creating new positions: 76 32
Funds Adding to an existing position: 59 6
Funds closing out their position: 58 10
Funds reducing their position: 122 10
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding MDSO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DOMINGUEZ CARLOS

  • Director
8,440 2019-08-05 1

MATEO ALAN EVP GLOBAL SALES

  • Officer
17,718 2019-08-01 0

CAPONE MICHAEL L

  • Director
25,000 2019-07-31 0

SHAPIRO LEE CHIEF FINANCIAL OFFICER

  • Officer
7,626,130 2019-07-29 1

SHERIF TAREK CHAIRMAN & CEO

  • Officer
  • Director
800,113 2019-06-17 4

DE VRIES GLEN MICHAEL PRESIDENT

  • Officer
  • Director
844,071 2019-06-17 5

OTNER MICHAEL I. EVP-GENERAL COUNSEL

  • Officer
82,217 2019-06-17 6

MCCULLOCH GEORGE

  • Director
75,088 2019-06-14 2

TAYLOR ROBERT

  • Director
41,757 2019-06-06 3

KURTZ NEIL M

  • Director
119,161 2019-05-29 1

RIVAS MARIA

  • Director
7,081 2019-05-29 3

SCHLOSS EILEEN

  • Director
11,811 2019-05-22 0

BERGMANN ROUVEN CHIEF FINANCIAL OFFICER

  • Officer
116,678 2019-05-13 9

LARSEN JILL EVP, HUMAN RESOURCES

  • Officer
45,381 2019-04-23 2

SHANNON DANIEL PATRICK EVP, GLOBAL PROFESSIONAL SVCS.

  • Officer
50,772 2019-03-12 5

PRAY MICHAEL EVP, GM GLOBAL SALES

  • Officer
62,134 2019-03-01 6

HIRSCHFELD STEVEN ISAAC VICE CHAIRMAN

  • Officer
28,756 2017-02-24 0

WEGER MARY EVP, HUMAN RESOURCES

  • Officer
0 2017-02-24 0

PINTO MICHAEL CHRISTOPHER EVP, GM OF GLOBAL SALES

  • Officer
61,591 2016-02-26 0

COLISTRA DAVID CHIEF ACCOUNTING OFFICER

  • Officer
10,462 2015-07-01 0

DOUGLAS CORY FORMER CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2015-05-16 0

SPIELMAN BRYAN CHARLES

  • EXECUTIVE VICE PRESIDENT
No longer subject to file 2015-02-10 0

WILHITE STEVEN EVP, CHIEF MARKETING OFFICER

  • Officer
3,738 2014-02-10 0

KRASNOW LINEENE NORRIS EVP-PRODUCT & MARKETING

  • Officer
57,366 2013-02-25 0

DALZIEL BRUCE D EVP-FINANCE

  • Officer
74,493 2011-12-19 0

SOBILOFF PETER

  • Director
10,000 2010-11-12 0

INSIGHT VENTURE PARTNERS IV LP

INSIGHT VENTURE ASSOCIATES IV, LLC

INSIGHT VENTURE PARTNERS IV (FUND B), L.P.

INSIGHT HOLDINGS GROUP, LLC

INSIGHT VENTURE PARTNERS IV (CO-INVESTORS), L.P.

INSIGHT VENTURE PARTNERS IV (CAYMAN), L.P.

  • 10% Owner
3,130,542 2010-08-16 0

INSIGHT VENTURE PARTNERS IV LP

INSIGHT VENTURE PARTNERS IV (FUND B), L.P.

INSIGHT VENTURE PARTNERS IV (CO-INVESTORS), L.P.

INSIGHT VENTURE PARTNERS IV (CAYMAN), L.P.

INSIGHT VENTURE ASSOCIATES IV, LLC

  • 10% Owner
0 2009-06-24 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments